1873.HK
Price:
$1.93
Market Cap:
$3.69B
Viva Biotech Holdings, an investment holding company, provides structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide. The company provides discovery biology services, include protein expression and purification, structural biology, hit discovery, bioassay, biomolecular interaction, and pharmacokinetics; chemistry services, such as medicinal and synthetic chemistry, analytical chemistry, purification preparation, and computer-aided drug design services, as well as offers chemical technology platforms; and antibody drug research and development services, include antigen preparation, multi-species discovery, monoclonal antibodies, antibodies functional ...[Read more]
Industry
Biotechnology
IPO Date
2019-05-09
Stock Exchange
HKSE
Ticker
1873.HK
According to Viva Biotech Holdings’s latest financial reports and current stock price. The company's current PE Ratio is 27.57. This represents a change of 569.27% compared to the average of 4.12 of the last 4 quarters.
The mean historical PE Ratio of Viva Biotech Holdings over the last ten years is 41.12. The current 27.57 PE Ratio has changed 6.60% with respect to the historical average. Over the past ten years (40 quarters), 1873.HK's PE Ratio was at its highest in in the June 2023 quarter at 656.96. The PE Ratio was at its lowest in in the June 2022 quarter at -11.51.
Average
41.12
Median
22.63
Minimum
-30.83
Maximum
242.47
Discovering the peaks and valleys of Viva Biotech Holdings PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 177.13%
Maximum Annual PE Ratio = 242.47
Minimum Annual Increase = -236.21%
Minimum Annual PE Ratio = -30.83
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | 10.32 | -167.45% |
| 2023 | -15.29 | 177.13% |
| 2022 | -5.52 | -121.64% |
| 2021 | 25.50 | -182.72% |
| 2020 | -30.83 | -236.21% |
| 2019 | 22.63 | -53.33% |
| 2018 | 48.49 | -32.99% |
| 2017 | 72.36 | -70.16% |
The current PE Ratio of Viva Biotech Holdings (1873.HK) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-3.50
5-year avg
-3.16
10-year avg
41.12
Viva Biotech Holdings’s PE Ratio is less than Medtide Inc. (0), greater than Qyuns Therapeutics Co., Ltd. (-21.26), greater than AIM Vaccine Co., Ltd. (-13.54), greater than Jacobio Pharmaceuticals Group Co., Ltd. (-135.05), greater than Shanghai Kindly Medical Instruments Co., Ltd. (25.81), greater than Modern Dental Group Limited (10.39), greater than ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (-8.19), greater than Jiangsu Recbio Technology Co., Ltd. (-3.64), greater than Antengene Corporation Limited (-11.01), greater than Ocumension Therapeutics (-23.73),
| Company | PE Ratio | Market cap |
|---|---|---|
| 0 | $4.04B | |
| -21.26 | $4.49B | |
| -13.54 | $4.13B | |
| -135.05 | $6.91B | |
| 25.81 | $5.43B | |
| 10.39 | $4.95B | |
| -8.19 | $2.64B | |
| -3.64 | $2.62B | |
| -11.01 | $2.73B | |
| -23.73 | $6.65B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Viva Biotech Holdings using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Viva Biotech Holdings or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Viva Biotech Holdings's PE Ratio?
How is the PE Ratio calculated for Viva Biotech Holdings (1873.HK)?
What is the highest PE Ratio for Viva Biotech Holdings (1873.HK)?
What is the 3-year average PE Ratio for Viva Biotech Holdings (1873.HK)?
What is the 5-year average PE Ratio for Viva Biotech Holdings (1873.HK)?
How does the current PE Ratio for Viva Biotech Holdings (1873.HK) compare to its historical average?